General Information of Drug (ID: DM1IZA7)

Drug Name
Benzimidazole Drug Info
Synonyms
BENZIMIDAZOLE; 51-17-2; 1H-Benzimidazole; 1H-Benzo[d]imidazole; 1,3-Benzodiazole; Benzoimidazole; o-Benzimidazole; 3-Azaindole; Benziminazole; Benzoglyoxaline; Azindole; 1,3-Diazaindene; 1H-Benzoimidazole; N,N'-Methenyl-o-phenylenediamine; NSC 759; Benzimidazol; 1H-1,3-benzodiazole; BZI; UNII-E24GX49LD8; CCRIS 5967; Benzimidazole, 98%; CHEBI:41275; HSDB 2797; EINECS 200-081-4; BRN 0109682; AI3-03737; E24GX49LD8; HYZJCKYKOHLVJF-UHFFFAOYSA-N; DSSTox_CID_4573; DSSTox_RID_77454; DSSTox_GSID_24573; F3366-5347; CAS-51-17-2; bezimidazole
Indication
Disease Entry ICD 11 Status REF
Cytomegalovirus Disease 1D82 Investigative [1]
Cross-matching ID
PubChem CID
5798
ChEBI ID
CHEBI:41275
CAS Number
CAS 51-17-2
TTD Drug ID
DM1IZA7

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Harmine DMPA5WD Discovery agent N.A. Patented [2]
PMID28766366-Compound-Scheme21Left DMWTRUK N. A. N. A. Patented [2]
PMID28766366-Compound-Scheme21Right DMF3X40 N. A. N. A. Patented [2]
PMID28766366-Compound-Scheme14BINDY DMBQ0RN N. A. N. A. Patented [2]
TG003 DMP4HR2 Discovery agent N.A. Patented [2]
PMID28766366-Compound-Scheme2WO2012/098065bottom DMO4Q95 N. A. N. A. Patented [2]
PMID28766366-Compound-Scheme16DMAT DMQ5UEA N. A. N. A. Patented [2]
PMID28766366-Compound-Scheme7WO2012/098070upper DMGAQR5 N. A. N. A. Patented [2]
PMID28766366-Compound-Scheme9EHT1610 DMMZGC8 N. A. N. A. Patented [2]
PMID28766366-Compound-Scheme9EHT5372 DM0O18N N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) TTSBVFO DYR1A_HUMAN Inhibitor [2]

References

1 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
2 Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199.